Physician profile
Jacqueline Benoit
NPI 1174182950
$2,609.37
in general payments reported to CMS, 2019-2025
16 companies · $649 in 2025
The $649 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,025 · 2020: $16.20 · 2021: $336 · 2022: $68.12 · 2023: $130 · 2024: $384 · 2025: $649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,164.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $926.33 | 2019-2024 | Argos, Total30 |
| Oyster Point Pharma, INC. | $248.67 | 2023-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Tarsus Pharmaceuticals, INC. | $228.02 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $169.52 | 2025 | Idosetr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $153.29 | 2021 | |
| Bausch & Lomb Americas INC. | $150.34 | 2022-2025 | Xiidra, Vyzulta, Miebo |
| Abbvie INC. | $125.05 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Coopervision INC. | $121.23 | 2019-2021 | |
| Biotissue Holdings INC. | $115.58 | 2024-2025 | |
| Johnson & Johnson Vision Care, INC. | $109.06 | 2019 | |
| Carl Zeiss Meditec, INC. | $86.67 | 2019 | |
| Dompe US, INC. | $60.48 | 2024 | Oxervate |
| Sight Sciences, INC. | $52.82 | 2024 | Tearcare System |
| Allergan, INC. | $23.68 | 2021 | |
| Horizon Therapeutics Plc | $22.43 | 2023 | Uplizna |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Benoit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.